Aviman Medicare Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
- Paid Up Capital ₹ 4.15 M
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 71.89%
- Profit Growth 33.63%
- Ebitda -104.85%
- Net Worth 11.31%
- Total Assets 2.15%
About Aviman Medicare
Aviman Medicare Private Limited (AMPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 March 2006 and has a history of 18 years and 11 months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 4.15 M, as per Ministry of Corporate Affairs (MCA) records.
Kishor Dharia, Arun Gandhi, and Santosh Butala serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230MH2006PTC160314
- Company No.
160314
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Mar 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Aviman Medicare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kishor Dharia  | Additional Director | 28-Nov-2024 | Current |
| Arun Gandhi | Director | 05-Mar-2018 | Current |
| Santosh Butala | Director | 10-Oct-2008 | Current |
Financial Performance of Aviman Medicare.
Aviman Medicare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 71.89% increase. The company also saw a substantial improvement in profitability, with a 33.63% increase in profit. The company's net worth Soared by an impressive increase of 11.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aviman Medicare?
In 2022, Aviman Medicare had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dharia Impex Private LimitedKishor Dharia is a mutual person
- Millenium Towers Private Limited
Santosh Butala is a mutual person
- Shree Samarth Chemoil Private Limited
Santosh Butala is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aviman Medicare?
Unlock and access historical data on people associated with Aviman Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aviman Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aviman Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
